Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNurix Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

Nurix Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $9.04M. Net result −$89.54M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $9.04M. Running result $9.04M. Collaboration Revenue: $9.04M. License Revenue: $0.
  • Cost of revenue: $0. Running result $9.04M.
  • Gross profit: $9.04M. Running result $9.04M.
  • Research and development: −$87.65M. Running result −$78.61M.
  • General and administrative: −$15.59M. Running result −$94.2M.
  • Operating income: −$94.2M. Running result −$94.2M.
  • Other income: $4.4M. Running result −$89.81M.
  • Pre-tax loss: −$89.81M. Running result −$89.81M.
  • Income tax benefit: $271K. Running result −$89.54M.
  • Net loss: −$89.54M. Running result −$89.54M.